Deidre Devier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Deidre Devier has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Jesus Lovera
Louisiana State University Health Sciences Center - New Orleans, United States
4 shared publications - Shannin Moody
Louisiana State University Health Sciences Center - New Orleans, United States
3 shared publications - Auriel A. Willette
Department of Neurology, Rutgers University, New Brunswick, NJ, USA
2 shared publications - Brain Copeland
Louisiana State University Health Sciences Center - New Orleans, United States
2 shared publications D.P. Devanand
Division of Geriatric Psychiatry, Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute, Bronx, N.Y., USA
2 shared publications- Morganne Manuel
Medical College of Georgia - Augusta University, United States
2 shared publications
Latest Publications
- Open Access
- 11 June 2026
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 191, 107935
Beyond perceived stress: Hair cortisol is linked with cognition and fatigue in black and white patients with multiple sclerosis
- 11 June 2026
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 191, 107935
Open AccessBeyond perceived stress: Hair cortisol is linked with cognition and fatigue in black and white patients with multiple sclerosis
- Open Access
- 17 September 2025
- Published by Elsevier in Clinical Parkinsonism & Related Disorders
- Vol. 13, 100395
A single Center study of the Symbol Digit Modalities test as a screening tool for cognitive impairment in Parkinson’s disease
- 17 September 2025
- Published by Elsevier in Clinical Parkinsonism & Related Disorders
- Vol. 13, 100395
Open AccessA single Center study of the Symbol Digit Modalities test as a screening tool for cognitive impairment in Parkinson’s disease
- 26 September 2024
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 466, 123260
The intersection of race and sex on the clinical and cognitive progression of multiple sclerosis
- 26 September 2024
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 466, 123260
The intersection of race and sex on the clinical and cognitive progression of multiple sclerosis
- 30 January 2023
- Published by SAGE Publications in Journal of Holistic Nursing
- Vol. 41 (4) , 347-359
Healing Touch: A Strategy for Acute Care Nurses’ Stress Reduction
The purpose of the study is to determine whether administering healing touch (HT) is more effective than deep breathing (DB) for reducing acute care nurses’ stress during a shift. A randomized cluster trial assessed 150 nurses’ vital signs and Visual Analog Scale for Stress (VASS) levels pre, post, and at follow-up to achieve a power of .7 and medium affect size. Open-ended questions following the intervention enriched quantitative findings describing the experience, facilitators, and barriers to potential use in nursing. The generalized estimating equation 1 (GEE1) comparisons of mean change over time, found that nurses in the HT intervention, had significantly lower VASS stress scores at posttreatment (−0.95, p = .0002) and at follow-up (−0.73, p = .0144) than the DB group, and the respiratory rate (RR) rate differences were nearly significant at post-intervention and significant at follow-up, respectively (1.36, p = .0568 and −2.28, p = .0011), indicating lower RR after HT. These findings support the use of HT as an effective stress reduction strategy as a relevant strategy to sustain a viable nurse work force post-COVID-19.
- 30 January 2023
- Published by SAGE Publications in Journal of Holistic Nursing
- Vol. 41 (4) , 347-359
Healing Touch: A Strategy for Acute Care Nurses’ Stress Reduction
The purpose of the study is to determine whether administering healing touch (HT) is more effective than deep breathing (DB) for reducing acute care nurses’ stress during a shift. A randomized cluster trial assessed 150 nurses’ vital signs and Visual Analog Scale for Stress (VASS) levels pre, post, and at follow-up to achieve a power of .7 and medium affect size. Open-ended questions following the intervention enriched quantitative findings describing the experience, facilitators, and barriers to potential use in nursing. The generalized estimating equation 1 (GEE1) comparisons of mean change over time, found that nurses in the HT intervention, had significantly lower VASS stress scores at posttreatment (−0.95, p = .0002) and at follow-up (−0.73, p = .0144) than the DB group, and the respiratory rate (RR) rate differences were nearly significant at post-intervention and significant at follow-up, respectively (1.36, p = .0568 and −2.28, p = .0011), indicating lower RR after HT. These findings support the use of HT as an effective stress reduction strategy as a relevant strategy to sustain a viable nurse work force post-COVID-19.
- 1 January 2021
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 420, 117202
A hypothesis-generating scoping review of miRs identified in both multiple sclerosis and dementia, their protein targets, and miR signaling pathways
- 1 January 2021
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 420, 117202
A hypothesis-generating scoping review of miRs identified in both multiple sclerosis and dementia, their protein targets, and miR signaling pathways
- Open Access
- 1 January 2018
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 384, 15-20
Unilateral repetitive transcranial magnetic stimulation differentially affects younger and older adults completing a verbal working memory task
- 1 January 2018
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 384, 15-20
Open AccessUnilateral repetitive transcranial magnetic stimulation differentially affects younger and older adults completing a verbal working memory task
- Open Access
Rehabilitation plus OnabotulinumtoxinA Improves Motor Function over OnabotulinumtoxinA Alone in Post-Stroke Upper Limb Spasticity: A Single-Blind, Randomized Trial
Background: OnabotulinumtoxinA (BoNT-A) can temporarily decrease spasticity following stroke, but whether there is an associated improvement in upper limb function is less clear. This study measured the benefit of adding weekly rehabilitation to a background of BoNT-A treatments for chronic upper limb spasticity following stroke. Methods: This was a multi-center clinical trial. Thirty-one patients with post-stroke upper limb spasticity were treated with BoNT-A. They were then randomly assigned to 24 weeks of weekly upper limb rehabilitation or no rehabilitation. They were injected up to two times, and followed for 24 weeks. The primary outcome was change in the Fugl–Meyer upper extremity score, which measures motor function, sensation, range of motion, coordination, and speed. Results: The ‘rehab’ group significantly improved on the Fugl–Meyer upper extremity score (Visit 1 = 60, Visit 5 = 67) while the ‘no rehab’ group did not improve (Visit 1 = 59, Visit 5 = 59; p = 0.006). This improvement was largely driven by the upper extremity “movement” subscale, which showed that the ‘rehab’ group was improving (Visit 1 = 33, Visit 5 = 37) while the ‘no rehab’ group remained virtually unchanged (Visit 1 = 34, Visit 5 = 33; p = 0.034). Conclusions: Following injection of BoNT-A, adding a program of rehabilitation improved motor recovery compared to an injected group with no rehabilitation.
Open AccessRehabilitation plus OnabotulinumtoxinA Improves Motor Function over OnabotulinumtoxinA Alone in Post-Stroke Upper Limb Spasticity: A Single-Blind, Randomized Trial
Background: OnabotulinumtoxinA (BoNT-A) can temporarily decrease spasticity following stroke, but whether there is an associated improvement in upper limb function is less clear. This study measured the benefit of adding weekly rehabilitation to a background of BoNT-A treatments for chronic upper limb spasticity following stroke. Methods: This was a multi-center clinical trial. Thirty-one patients with post-stroke upper limb spasticity were treated with BoNT-A. They were then randomly assigned to 24 weeks of weekly upper limb rehabilitation or no rehabilitation. They were injected up to two times, and followed for 24 weeks. The primary outcome was change in the Fugl–Meyer upper extremity score, which measures motor function, sensation, range of motion, coordination, and speed. Results: The ‘rehab’ group significantly improved on the Fugl–Meyer upper extremity score (Visit 1 = 60, Visit 5 = 67) while the ‘no rehab’ group did not improve (Visit 1 = 59, Visit 5 = 59; p = 0.006). This improvement was largely driven by the upper extremity “movement” subscale, which showed that the ‘rehab’ group was improving (Visit 1 = 33, Visit 5 = 37) while the ‘no rehab’ group remained virtually unchanged (Visit 1 = 34, Visit 5 = 33; p = 0.034). Conclusions: Following injection of BoNT-A, adding a program of rehabilitation improved motor recovery compared to an injected group with no rehabilitation.
- Open Access
- 1 November 2015
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 358 (1-2) , 46-52
Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies
- 1 November 2015
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 358 (1-2) , 46-52
Open AccessPolyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies
- Open Access
- 15 September 2010
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 30 (3) , 238-244
Predictive Utility of Type and Duration of Symptoms at Initial Presentation in Patients with Mild Cognitive Impairment
Background/Aims: To assess (1) the duration and symptoms present in participants with mild cognitive impairment (MCI) and (2) the impact of these variables on predicting conversion to Alzheimer’s disease (AD). Methods: Participants with MCI (n = 148) were assessed and followed systematically. Results: Decline in memory was reported as the first symptom in 118 of the cases. Converters had more symptoms (e.g. language decline, depression), and the combination of decline in memory and in performance of high-order social/cognitive activities as well as disorientation more often than nonconverters (p = 0.036). In an age-stratified Cox model, predictors of conversion to AD were shorter time since onset of memory decline and lower baseline MMSE score. Conclusions: Recent onset of memory decline with older age, decreased MMSE score, change in performance and disorientation indicate a greater likelihood of short-term conversion to AD.
- 15 September 2010
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 30 (3) , 238-244
Open AccessPredictive Utility of Type and Duration of Symptoms at Initial Presentation in Patients with Mild Cognitive Impairment
Background/Aims: To assess (1) the duration and symptoms present in participants with mild cognitive impairment (MCI) and (2) the impact of these variables on predicting conversion to Alzheimer’s disease (AD). Methods: Participants with MCI (n = 148) were assessed and followed systematically. Results: Decline in memory was reported as the first symptom in 118 of the cases. Converters had more symptoms (e.g. language decline, depression), and the combination of decline in memory and in performance of high-order social/cognitive activities as well as disorientation more often than nonconverters (p = 0.036). In an age-stratified Cox model, predictors of conversion to AD were shorter time since onset of memory decline and lower baseline MMSE score. Conclusions: Recent onset of memory decline with older age, decreased MMSE score, change in performance and disorientation indicate a greater likelihood of short-term conversion to AD.
- 13 November 2009
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 24 (12) , 1335-1342
The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease
Objective To compare state and trait anxiety in mild cognitive impairment (MCI) patients and matched control subjects, and to assess the impact of these variables in predicting conversion to Alzheimer's disease. Methods One hundred and forty‐eight patients with MCI, broadly defined, were assessed and followed systematically. Baseline predictors for follow‐up conversion to AD (entire sample: 39/148 converted to Alzheimer's disease (AD)) included the Spielberger State‐Trait Anxiety Inventory (STAI). Results At baseline evaluation, MCI patients had higher levels of state and trait anxiety than controls, with no differences between future AD converters (n = 39) and non‐converters. In age‐stratified Cox proportional hazards model analyses, STAI State was not a significant predictor of conversion to AD (STAI State ≤30 vs. > 30 risk ratio, 1.68; 95% CI, 0.75, 3.77; p = 0.21), but higher Trait scores indicated a lower risk of conversion when STAI State, education, the Folstein Mini‐Mental State Examination and HAM‐D (depression score) were also included in the model (STAI Trait ≤30 vs. > 30 risk ratio, 0.36; 95% CI, 0.16, 0.82; p = 0.015). Conclusions In contrast to two other recent studies that showed anxiety predicted cognitive decline or conversion to AD, in this clinic‐based sample, state anxiety was not a significant predictor. However, higher Trait anxiety predicted a lower risk of future conversion to AD. Further research with systematic long‐term follow‐up in larger samples is needed to clarify the role of state and trait anxiety in predicting MCI conversion to AD. Copyright © 2009 John Wiley & Sons, Ltd.
- 13 November 2009
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 24 (12) , 1335-1342
The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease
Objective To compare state and trait anxiety in mild cognitive impairment (MCI) patients and matched control subjects, and to assess the impact of these variables in predicting conversion to Alzheimer's disease. Methods One hundred and forty‐eight patients with MCI, broadly defined, were assessed and followed systematically. Baseline predictors for follow‐up conversion to AD (entire sample: 39/148 converted to Alzheimer's disease (AD)) included the Spielberger State‐Trait Anxiety Inventory (STAI). Results At baseline evaluation, MCI patients had higher levels of state and trait anxiety than controls, with no differences between future AD converters (n = 39) and non‐converters. In age‐stratified Cox proportional hazards model analyses, STAI State was not a significant predictor of conversion to AD (STAI State ≤30 vs. > 30 risk ratio, 1.68; 95% CI, 0.75, 3.77; p = 0.21), but higher Trait scores indicated a lower risk of conversion when STAI State, education, the Folstein Mini‐Mental State Examination and HAM‐D (depression score) were also included in the model (STAI Trait ≤30 vs. > 30 risk ratio, 0.36; 95% CI, 0.16, 0.82; p = 0.015). Conclusions In contrast to two other recent studies that showed anxiety predicted cognitive decline or conversion to AD, in this clinic‐based sample, state anxiety was not a significant predictor. However, higher Trait anxiety predicted a lower risk of future conversion to AD. Further research with systematic long‐term follow‐up in larger samples is needed to clarify the role of state and trait anxiety in predicting MCI conversion to AD. Copyright © 2009 John Wiley & Sons, Ltd.